[The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
作者信息
Hasdai D, Gottlieb S, Godbourt U, Hod H, Kaluski E
出版信息
Harefuah. 2002 Oct;141(10):922-4.
PMID:12420602
Abstract
摘要
相似文献
1
[The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].[环氧化酶-2（COX-2）抑制剂的心血管安全性]
Harefuah. 2002 Oct;141(10):922-4.
2
[The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].[非甾体抗炎药（NSAIDs）——COX-2抑制剂的使用]
Harefuah. 2002 Oct;141(10):920-1.
3
Celecoxib: a COX-2 inhibitor.塞来昔布：一种环氧化酶-2抑制剂。
Am J Manag Care. 1999 Apr;5(4):511-8; quiz 522-4.
4
5
COX-2 inhibitors: new drugs for the management of pain and inflammation.环氧化酶-2抑制剂：用于疼痛和炎症管理的新药。
Dent Today. 2001 Feb;20(2):56-61.
6
[Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
MMW Fortschr Med. 2003 Jul 24;145(29-30):61.
7
[COX-2 inhibitor to whom?].[环氧化酶-2抑制剂适用于谁？]
Duodecim. 2000;116(12):1265-7.
8
[Selective COX-2 inhibitors for therapy of rheumatoid arthritis].
Nihon Rinsho. 2005 Jan;63 Suppl 1:477-87.
9
Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.COX-2特异性抑制剂的疗效、安全性及潜在临床作用。
Int J Immunopathol Pharmacol. 2003 May-Aug;16(2 Suppl):17-22.
10
Cox-2 inhibitors: a new class of medication?
Med Health R I. 1999 Sep;82(9):332-4.
Zotero 插件